In this presentation, we will introduce the student to diagnosis of chronic infections. Diagnosing chronic infections is just as complicated as treating these infections. In continuation of this, we will talk about the three main issues when diagnosing chronic infections and share some experiences we have within this area.

In this presentation, we will introduce you to evolution in biofilms and chronic infections. The general principles of evolution are independent of the specific environment, however some conditions related to time and space are faced by bacteria in chronic infections - and this affects evolution

In this presentation, we will tell you about social evolution in microbes and in continuation of this discuss why social evolution in microbes is important in biofilms.

In this presentation, we will discuss how bacteria are causing disease. Furthermore, we will introduce the student to the term pathogenesis, and in continuation of this present the four main steps, that causes pathogenesis.

The aim of this presentation is to expand the student knowledge about biofilms on central venous catheters (CVC). In continuation of this, we will discuss how to avoid infections regarding CVCs.

In this presentation, we will introduce Oral Biofilms, such as the dental biofilm, also known as dental plaque. The dental biofilm is associated with some of the most well known oral diseases like caries and periodontal disease but it also has beneficial effects.

This presentation will introduce otitis media and chronic ear infections. In continuation of this, we will talk about how middle ear disease affects the populations and why we have to speculate about biofilms in otitis media.

The aim of this presentation is to provide a brief overview of issues related to the treatment of chronic deep infections around joint replacements. In continuation of this, we will discuss what the symptoms are, how to establish the diagnosis and choose what kind of treatment to use, in different phases of the infection.

In this presentation, we will talk about bacteria, and the two life forms planktonic and biofilm growing bacteria. In continuation of this we will explain the difference between planktonic and biofilm growing bacteria.

The aim of this presentation is to expand the student knowledge about skin microbiology. The main skin microbes are bacteria, viruses and fungi, which normally are friendly without causing harms. However, the skin flora is constantly challenges by our every-day life activities.

The focus of this presentation is to expand the students’ knowledge about the Human Gut Microbiome. The gut is - similar to the skin - exposed externally and is therefore a non-sterile environment.

In this presentation, we will tell you about dermal gel fillers and infections related to these. Dermal gel fillers have become increasingly popular during the past 15-20 years, because they can restore some of the youthful appearance in an ageing face. The fillers differ in longevity and composition, some contain micro particles and others do not.

The aim of this presentation is to expand the students’ knowledge about treatment of chronic infections in relation to orthopedic surgery. In the field of orthopedic surgery, several chronic infections exist and sometimes they combine.

In this presentation, we will discuss how to treat chronic infections. In continuation of this, we will discuss some of the issues that one might consider when treating biofilm-associated infections.

The aim of this presentation is to address different hot topics in our current understanding of aetiology as well as of the pathophysiology of Type 2 Diabetes. We’ll address how genetic as well as epi-genetic and non-genetic mechanisms may be involved in the complex mechanisms underlying type 2 diabetes. We’ll also introduce recent data suggesting that immature stem-cell functions are likely to play an important role for development of type 2 diabetes and its associated cardiometabolic disturbances. Finally we’ll address the current treatment options of disease with respect of both pharmacological and non-pharmacological treatment modalities.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentation address the multifactorial etiology of type 2 diabetes. The multifactorial etiology, can be divided into three major categories, primary predisposing factors, secondary precipitating factors, as well as tertiary accelerating factors.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

The aim of this presentation is to address and understand the paradigm shifting consequences of the Thrifty Phenotype Hypothesis as a conceptual framework to understand the roots of type 2 diabetes.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

During the last couple of decades two new remarkably successful principles for diabetes therapy have appeared and are now used worldwide. These are incretin based therapy and surgical therapy. These two are at some extent linked together and in this lecture we’ll provide an introduction to these two principles for diabetes therapy.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

In this presentation we’ll talk about the effects of GLP-1 (Glucagon Like Peptide 1), GLP-1 has important actions on gastrointestinal secretion and motility, and it acts to inhibit appetite and food intake. In continuation of the effects of GLP-1, we’ll talk about GLP-1, GIP, lipids, proteins, and dipeptidyl peptidase-4.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentation talks about intravenously GLP-1 infusion to patients with type 2 diabetes. The GLP-1 infusion is capable of restoring fasting glucose concentrations during the night time and can nearly normalize the meal-induced glucose excursions after meal ingestion. GLP-1 has many attractive actions regarding diabetes type 2 treatment, which is the theme of this presentation.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst